SOPHIA ANTIPOLIS, France, Sept. 3 (TNSres) -- The European Society of Cardiology issued the following news release: * * * Key take-aways * In the EPIC-CAD trial, edoxaban monotherapy was associated with better net clinical benefit than edoxaban plus a single antiplatelet agent, when given as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation and stable coronary artery disease. * The favourable clinical benefit observed with edoxaban monotherapy was driven by a  more

SOPHIA ANTIPOLIS, France, Sept. 3 (TNSres) -- The European Society of Cardiology issued the following news release: * * * OCCUPI randomised trial finds optical coherence tomography significantly improves clinical outcomes and enhances safety and effectiveness of coronary stenting Key take-aways OCCUPI randomised trial finds optical coherence tomography (OCT) reduced the combined risk of cardiac death, heart attacks, stent thrombosis, and the need for revascularisation by 38% compared to conv  more

SOPHIA ANTIPOLIS, France, Sept. 3 (TNSres) -- The European Society of Cardiology issued the following news release: * * * Key take-aways * In the largest trial to date in this population, the SENIOR-RITA trial showed no significant reduction in the combined risk of cardiovascular death or non-fatal myocardial infarction (MI) with an invasive strategy vs. a conservative strategy to treat patients aged 75 years who had a non-ST-elevation MI (NSTEMI). * A significant reduction in the risk of   more